Translationalneurodegeneration.com

Countable Data Brief

Translationalneurodegeneration.com is tracked by us since September, 2014. Over the time it has been ranked as high as 1 127 399 in the world, while most of its traffic comes from USA, where it reached as high as 512 217 position. It was owned by several entities, from TOMAS RAMANAUSKAS of BIOMED CENTRAL to Ramanauskas Tomas of BiomedCentral, it was hosted by Springer-Verlag Heidelberg, Fastly Inc. and others. While ENOM INC. was its first registrar, now it is moved to EuroDNS S.A..

Translationalneurodegeneration has a high Google pagerank and bad results in terms of Yandex topical citation index. We found that Translationalneurodegeneration.com is poorly ‘socialized’ in respect to any social network. According to Google safe browsing analytics, Translationalneurodegeneration.com is quite a safe domain with no visitor reviews.

Traffic Analysis

It seems that the number of visitors and pageviews on this site is too low to be displayed, sorry.

SEO Stats

Translationalneurodegeneration.com has Google PR 6 and its top keyword is "Neurodegeneration" with 12.09% of search traffic.

Social Engagement

Translationalneurodegeneration.com has 0% of its total traffic coming from social networks (in last 3 months) and the most active engagement is detected in Facebook (345 shares)

Safety

Safety status of Translationalneurodegeneration.com is described as follows: Google Safe Browsing reports its status as safe.